Home/Filings/4/0001104659-20-132151
4//SEC Filing

Singer William S. 4

Accession 0001104659-20-132151

CIK 0001513856other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 9:40 PM ET

Size

24.9 KB

Accession

0001104659-20-132151

Insider Transaction Report

Form 4
Period: 2020-12-01
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-019,3750 total
    Exercise: $32.00Common Stock (9,375 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-011,5630 total
    Exercise: $71.04Common Stock (1,563 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-0172,5000 total
    Exercise: $0.97Common Stock (72,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-011,5630 total
    Exercise: $35.52Common Stock (1,563 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-0110,0000 total
    Exercise: $4.06Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-0115,5350 total
    Exercise: $10.56Common Stock (15,535 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-0125,0000 total
    Exercise: $3.93Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-0110,0000 total
    Exercise: $19.10Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-0110,0000 total
    Exercise: $8.91Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-12-0110,0000 total
    Exercise: $0.82Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. ("Petros"), Neurotrope, Inc. ("Neurotrope"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the "Merger Agreement") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held.

Issuer

Neurotrope, Inc.

CIK 0001513856

Entity typeother

Related Parties

1
  • filerCIK 0001617927

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 9:40 PM ET
Size
24.9 KB